Kyowa Hakko News Releases 1999
- November 1, 1999
- Fancl succeeded in launching a new hair-growing agent, a quasi-drug “Medicated Mohkatsurin PB”, from collaboration with Kyowa Hakko
- September 20, 1999
- Phase Ⅱ clinical study of an antiparkinson agent started in the USA
- September 13, 1999
- Publishing a Booklet “Health, Safety, and the Environment” (in Japanese and English)
Environment- and Safety-Related Cost and Volume of Emissions Having the Environmental Impact Shown in Actual Figures - September 3, 1999
- Establishment of a Venture Company on the Analysis of functional genomics of human
- August 31, 1999
- Mitsubishi Chemical Corporation / Kyowa Hakko Kogyo Co., Ltd.
To Establish a Joint Venture for Plasticizers Business - August 19, 1999
- Launching “Form Up® Doucé -GM”,
A New Amino Acid Surfactant of Low Irritability - August 4, 1999
- Raw Material for Cosmetics with Skin Whitening Effect
Market Launching of “Sodium L-Ascorbyl-L-Phosphate” - June 22, 1999
- Complete genome sequence of Corynebacterium glutamicum
almost determined - May 10, 1999
- Launch of “Navelbine”, an anticancer agent
to be used in the treatment of non-small cell lung cancer - March 18, 1999
- Kyowa Medex Co., Ltd. has concluded a license agreement
to introduce diagnostic kits for Alzheimer's Disease
from Synapse Technologies Inc. in Canada - March 15, 1999
- “Vinorelbine Tartrate”
NDA approval of A New Anticanser Drug - February 25, 1999
- Kyowa Medex Co., Ltd.
has concluded an agreement to supply
Sanofi Diagnostics Pasteur with a fully automated
device for microplate enzymatic immunoassay
